WO2009063505A3 - Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide - Google Patents

Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide Download PDF

Info

Publication number
WO2009063505A3
WO2009063505A3 PCT/IN2008/000647 IN2008000647W WO2009063505A3 WO 2009063505 A3 WO2009063505 A3 WO 2009063505A3 IN 2008000647 W IN2008000647 W IN 2008000647W WO 2009063505 A3 WO2009063505 A3 WO 2009063505A3
Authority
WO
WIPO (PCT)
Prior art keywords
oxo
fluoro
morpholinyl
acetamide
methyl
Prior art date
Application number
PCT/IN2008/000647
Other languages
French (fr)
Other versions
WO2009063505A2 (en
Inventor
Dhananjay Govind Sathe
Nandu Baban Bhise
Avinash Vankatraman Naidu
Kamlesh Digambar Sawant
Anindya Sibnath Bhattacharyya
Tushar Anil Naik
Original Assignee
Usv Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Limited filed Critical Usv Limited
Publication of WO2009063505A2 publication Critical patent/WO2009063505A2/en
Publication of WO2009063505A3 publication Critical patent/WO2009063505A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2

Abstract

The present invention provides novel process for preparation of (S)-N-[[3-[3-Fluoro-4-(4- morpholinyl)phenyl]-2-oxo-5-oxazolidinyl] methyl] -acetamide which comprises combining (R)-N-[3-[3-fluoro-4-morpholinyl phenyl]-2-oxo-5-oxazolidinyl]methylazide in suitable solvent, acetylating agent and acid in presence of a catalyst.
PCT/IN2008/000647 2007-10-08 2008-10-07 Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide WO2009063505A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2003/MUM/2007 2007-10-08
IN2003MU2007 2007-10-08

Publications (2)

Publication Number Publication Date
WO2009063505A2 WO2009063505A2 (en) 2009-05-22
WO2009063505A3 true WO2009063505A3 (en) 2009-11-12

Family

ID=40564952

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000647 WO2009063505A2 (en) 2007-10-08 2008-10-07 Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide

Country Status (1)

Country Link
WO (1) WO2009063505A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
EP2516408A1 (en) * 2009-12-26 2012-10-31 Alembic Pharmaceuticals Limited Process for the preparation of linezolid
CN103140487A (en) 2010-08-11 2013-06-05 斯索恩有限公司 Process for making linezolid
EP2603506A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
ES2555139T3 (en) 2011-02-24 2015-12-29 Lee Pharma Limited New procedure for the preparation of Linezolid and its new intermediates
EP2683696A1 (en) 2011-03-09 2014-01-15 Synthon BV Process for making crystalline form a of linezolid
CN102766106A (en) * 2011-05-03 2012-11-07 江苏豪森医药集团有限公司 Novel crystal form of linezolid and preparation method thereof
CN102260222B (en) * 2011-05-20 2015-05-13 上海医药工业研究院 Linezolid crystal form V and preparation method thereof
CN102321040B (en) * 2011-07-14 2013-08-21 扬子江药业集团南京海陵药业有限公司 Method for preparing linezolid intermediate and linezolid
CN102321041B (en) * 2011-07-20 2013-09-25 华润赛科药业有限责任公司 Preparation method of linezolid
CN102993192B (en) * 2011-09-14 2016-06-08 南开大学 A kind of oxazolidinone compounds and its preparation method and application
WO2013072923A1 (en) 2011-09-19 2013-05-23 Cadila Healthcare Limited Process for the preparation of crystalline linezolid
WO2013111048A1 (en) * 2012-01-24 2013-08-01 Jubilant Life Sciences Limited Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
ITMI20120655A1 (en) * 2012-04-19 2013-10-20 Bioindustria Lab Italiano M Edicinali Spa PROCEDURE FOR THE PREPARATION OF LINEZOLID
WO2014045292A1 (en) * 2012-09-20 2014-03-27 Symed Labs Limited Improved process for the preparation of linezolid intermediate
EP2917189B1 (en) 2012-11-09 2016-08-17 Synthon BV Process for making linezolid
CN105111160B (en) * 2015-09-11 2017-04-12 浙江新东港药业股份有限公司 Linezolid preparation method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007271A1 (en) * 1993-09-09 1995-03-16 The Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
WO2006110155A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd Solid forms of linezolid and processes for preparation thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007271A1 (en) * 1993-09-09 1995-03-16 The Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
WO2006110155A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd Solid forms of linezolid and processes for preparation thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ERIC F. V. SCRIVEN, KENNETH TURNBULL: "Azides: Their Preparation and Synthetic Uses", CHEMICAL REVIEWS, vol. 88, no. 2, 1988, pages 297 - 368, XP002525610 *
LOHRAY B B ET AL: "A Short Synthesis of Oxazolidinone Derivatives Linezolid and Eperezolid: A New Class of Antibacterials", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, vol. 40, no. 26, 25 June 1999 (1999-06-25), pages 4855 - 4856, XP004168663, ISSN: 0040-4039 *

Also Published As

Publication number Publication date
WO2009063505A2 (en) 2009-05-22

Similar Documents

Publication Publication Date Title
WO2009063505A3 (en) Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide
EP2447310A3 (en) Mixtures containing 1,1,1,3,3,3-hexafluorobutene and 1-chloro-3,3,3-trifluoropropene
WO2009001060A3 (en) Use of compounds for preparing anti-tuberculosis agents
WO2008127300A3 (en) Oxazolidinone derivatives and methods of use
WO2009137391A3 (en) Benzene sulfonamide thiazole and oxazole compounds
CL2013002241A1 (en) Compounds derived from (4,4'-biphenylbis (1h-imidazol-4,2-diyl) -2,1-pyrrolidindiyl ((1s) -1 - ((2r, 6r) -2,4-dimethyltetrahydro-2h-pyran -4-yl) -2-oxo-2,1-ethanediyl))) dimethyl biscarbamate, vhc inhibitors; intermediary compounds; pharmaceutical composition; pharmaceutical combination; and use to treat a vhc infection.
EP2265591A4 (en) Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture
JO3440B1 (en) Use of Agomelatine in Obtaining Medicaments Intended For The Treatment of Generalized Anxiety Disorder
WO2008088540A3 (en) N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases
DE602008001206D1 (en) Abrasive cleaning agent, process for its preparation and polishing process using the abrasive cleaning agent
HRP20130585T1 (en) Alkylthiazol carbamate derivatives, preparation thereof and their use as faah inhibitors
WO2010084514A3 (en) A process for the preparation of (5s)-(n)-[[3-[3-fluoro-4-(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide
CL2011001405A1 (en) Procedure for the preparation of n- [2- (7-methoxy-1-naphthyl) ethyl] acetamide, agomethalin.
WO2010142678A3 (en) Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide
IL179346A0 (en) 3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
MX2009003974A (en) N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression.
WO2010107435A8 (en) A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
NZ609964A (en) Pharmaceutical compositions
EP2072505A3 (en) A process for the preparation of oxazolidinone derivatives
DE102007016659B8 (en) Infusion pump, channel plate for an infusion pump and method of making the same
MX2013006031A (en) Liposomal formulation of dalcetrapib.
MY145139A (en) Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndrome
WO2014141067A3 (en) Process for the preparation of oxazolidinone derivatives
WO2006122012A3 (en) Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate
WO2003097059A8 (en) Polymorphic forms of phenyl oxazolidinone derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08850013

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08850013

Country of ref document: EP

Kind code of ref document: A2